Cargando…
Successful use of daily intravenous infusion of C1 esterase inhibitor concentrate in the treatment of a hereditary angioedema patient with ascites, hypovolemic shock, sepsis, renal and respiratory failure
Hereditary angioedema (HAE) is a rare autosomal dominant disease most commonly associated with defects in C1 esterase inhibitor (C1-INH). HAE manifests as recurrent episodes of edema in various body locations. Atypical symptoms, such as ascites, acute respiratory distress syndrome, and hypovolemic s...
Autores principales: | Pham, Hoang, Santucci, Stephanie, Yang, William H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268856/ https://www.ncbi.nlm.nih.gov/pubmed/25520740 http://dx.doi.org/10.1186/s13223-014-0062-9 |
Ejemplares similares
-
Early presentation of clinical hereditary angioedema symptoms in an infant
por: Pham, Hoang, et al.
Publicado: (2014) -
Self-administration of intravenous C1 esterase inhibitor (Berinertâ) in patients with Hereditary Angioedema decreases number of days spent in an emergency room
por: Rizk, Caroline, et al.
Publicado: (2011) -
Recombinant Human C1 Esterase Inhibitor in the Management of Hereditary Angioedema
por: Riedl, Marc
Publicado: (2015) -
Biochemical comparison of four commercially available C1 esterase inhibitor concentrates for treatment of hereditary angioedema
por: Feussner, Annette, et al.
Publicado: (2014) -
Self-administered C1 esterase inhibitor concentrates for the management of hereditary angioedema: usability and patient acceptance
por: Li, Huamin Henry
Publicado: (2016)